Browse Pet Safety Reports
29,491 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 29,491 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 29,491 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jun 22, 2017 | Dog | Newfoundland | Oclacitinib Maleate | Pruritus | Recovered/Normal |
| Jun 22, 2017 | Dog | Retriever - Golden | Moxidectin | Facial swelling (see also 'Skin'); Pruritus; Hives (see also 'Skin') | Ongoing |
| Jun 21, 2017 | Dog | Retriever - Labrador | Afoxolaner | Pruritus; Erythema (for urticaria see Immune SOC); Loose stool; Alopecia local | Outcome Unknown |
| Jun 21, 2017 | Dog | Sheepdog - Shetland | Sarolaner | Pruritus; Lethargy (see also Central nervous system depression in 'Neurologic... | Recovered/Normal |
| Jun 21, 2017 | Cat | Domestic Shorthair | Imidacloprid; Moxidectin | Application site pruritus | Outcome Unknown |
| Jun 21, 2017 | Dog | Pug | Florfenicol/Terbinafine Hydrochloride... | Pruritus; Lack of efficacy - NOS | Recovered/Normal |
| Jun 20, 2017 | Dog | Shepherd Dog - Belgian Mali... | Afoxolaner | Pruritus | Outcome Unknown |
| Jun 20, 2017 | Dog | Chihuahua | Grapiprant | Appetite loss; Vocalisation; Inappropriate defecation; Behavioural disorder N... | Ongoing |
| Jun 20, 2017 | Dog | Dog (unknown) | Sarolaner | Behavioural disorder NOS; Tremor; Anxiety; Pruritus | Ongoing |
| Jun 20, 2017 | Dog | Chihuahua | Sarolaner | Vomiting; Pruritus; Loose stool; Elevated creatine-kinase (CK); Elevated live... | Outcome Unknown |
| Jun 20, 2017 | Dog | Schnauzer (unspecified), Do... | Spinosad; Milbemycin Oxime | Lethargy (see also Central nervous system depression in 'Neurological'); Drun... | Outcome Unknown |
| Jun 19, 2017 | Dog | Shepherd Dog - German | Afoxolaner | Pruritus | Recovered/Normal |
| Jun 19, 2017 | Cat | Domestic Shorthair | Praziquantel; Emodepside | Application site alopecia; Application site erythema; Application site prurit... | Outcome Unknown |
| Jun 19, 2017 | Dog | Chihuahua | Afoxolaner | Pruritus; Erythema (for urticaria see Immune SOC); Skin disorders NOS | Ongoing |
| Jun 18, 2017 | Dog | Retriever - Golden | Afoxolaner | Dry skin; Flaking skin; Pruritus; Hair loss NOS | Outcome Unknown |
| Jun 18, 2017 | Human | Unknown | Imidacloprid; Moxidectin | Pruritus; Erythema (for urticaria see Immune SOC) | Recovered/Normal |
| Jun 18, 2017 | Dog | Shepherd Dog - Australian | Afoxolaner | Pruritus; Erythema (for urticaria see Immune SOC) | Outcome Unknown |
| Jun 18, 2017 | Dog | Shepherd Dog - Australian | Afoxolaner | Pruritus; Behavioural disorder NOS | Outcome Unknown |
| Jun 18, 2017 | Cat | Domestic Shorthair | Praziquantel; Emodepside | Application site pruritus; Application site alopecia; Alopecia | Outcome Unknown |
| Jun 17, 2017 | Dog | Retriever - Labrador | Spinosad; Milbemycin Oxime | Pruritus; Pinnal reddening; Pinnal oedema; Ear irritation; Alopecia general | Ongoing |
| Jun 17, 2017 | Dog | Crossbred Canine/dog | Imidacloprid; Moxidectin | Application site pruritus; Application site inflammation; Application site er... | Outcome Unknown |
| Jun 17, 2017 | Dog | Terrier (unspecified) | Fluralaner Chew Tablets | Pruritus; Abnormal cytology; Bacterial skin infection NOS | Ongoing |
| Jun 17, 2017 | Dog | Retriever - Golden | Afoxolaner 136 Mg Chewable Tablets | Pruritus; Lethargy (see also Central nervous system depression in 'Neurologic... | Recovered/Normal |
| Jun 17, 2017 | Dog | Mastiff | Afoxolaner | Pruritus; Skin lesion NOS; Pustules; Skin slough | Outcome Unknown |
| Jun 17, 2017 | Cat | Domestic Shorthair | Selamectin | Application site alopecia; Application site pruritus; Application site erythema | Recovered/Normal |
| Jun 16, 2017 | Dog | Retriever - Golden | Afoxolaner | Pruritus | Recovered/Normal |
| Jun 16, 2017 | Dog | Corgi (unspecified) | Carprofen | Erythema (for urticaria see Immune SOC); Pruritus; Pyoderma; Dry coat | Ongoing |
| Jun 16, 2017 | Dog | Collie - Border | Afoxolaner | Pruritus; Hair loss NOS; Tachycardia | Outcome Unknown |
| Jun 16, 2017 | Dog | Pit Bull, Dog (unknown) | Milbemycin Oxime; Praziquantel | Pruritus; Reddening of the skin; Lethargy (see also Central nervous system de... | Ongoing |
| Jun 16, 2017 | Cat | Domestic Shorthair | Imidacloprid; Moxidectin | Agitation; Lethargy (see also Central nervous system depression in 'Neurologi... | Recovered/Normal |
| Jun 16, 2017 | Dog | Dog (other) | Afoxolaner | Pruritus; Crying | Outcome Unknown |
| Jun 16, 2017 | Dog | Dog (other) | Afoxolaner 136 Mg Chewable Tablets | Pruritus | Recovered/Normal |
| Jun 15, 2017 | Dog | Terrier - Tibetan | Afoxolaner | Pruritus | Outcome Unknown |
| Jun 15, 2017 | Dog | Retriever - Labrador, Chow ... | Oclacitinib Maleate | Diarrhoea; Pruritus; Eye redness; Swelling NOS | Ongoing |
| Jun 15, 2017 | Cat | Domestic Shorthair | Imidacloprid; Moxidectin | Pruritus | Outcome Unknown |
| Jun 15, 2017 | Cat | Siamese | Fluralaner Spot-On Solution | Application site pruritus; Application site scab | Ongoing |
| Jun 15, 2017 | Cat | Domestic Shorthair | Selamectin | Application site pruritus; Application site reddening; Application site alopecia | Ongoing |
| Jun 15, 2017 | Dog | Chihuahua | Imidacloprid; Moxidectin | Pruritus; Skin sore | Outcome Unknown |
| Jun 15, 2017 | Dog | Dog (unknown) | Afoxolaner | Pruritus | Outcome Unknown |
| Jun 15, 2017 | Dog | Hound - Basset | Afoxolaner | Pruritus | Outcome Unknown |
| Jun 15, 2017 | Dog | Crossbred Canine/dog, Retri... | Fluralaner Chew Tablets | Skin inflammation NOS; Pruritus | Outcome Unknown |
| Jun 14, 2017 | Dog | Boxer (German Boxer) | Afoxolaner | Pruritus | Outcome Unknown |
| Jun 14, 2017 | Dog | Terrier - Boston | Afoxolaner | Pruritus | Outcome Unknown |
| Jun 14, 2017 | Cat | Domestic Shorthair | Selamectin | Application site pruritus; Application site hair loss; Application site scab;... | Outcome Unknown |
| Jun 14, 2017 | Dog | Poodle - Standard | Imidacloprid | Pruritus; Lack of efficacy (ectoparasite) - NOS | Outcome Unknown |
| Jun 14, 2017 | Dog | Spaniel - King Charles Cava... | Ivermectin; Pyrantel As Pamoate Salt | Pruritus | Outcome Unknown |
| Jun 14, 2017 | Dog | Retriever - Golden | Afoxolaner | Pruritus | Recovered/Normal |
| Jun 14, 2017 | Dog | Crossbred Canine/dog | Moxidectin | Agitation; Anxiety; Pruritus | Ongoing |
| Jun 14, 2017 | Dog | Collie - Border | Afoxolaner 68 Mg Chewable Tablets | Pruritus | Outcome Unknown |
| Jun 14, 2017 | Dog | Pug | Sarolaner | Pruritus | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.